KIITEE Phase 1 Results 2025 has ... for KIITEE 2025 but missed Phase 1 registration can register for Phase II registrations . Registrations for KIITEE Phase 2 will begin on June 8, and the exam ...

The Kalinga Institute of Industrial Technology has released the KIITEE 2025 Phase 1 results for its entrance exam. Candidates can now check their scores, subject-wise marks, and overall rank ...

The Kalinga Institute of Industrial Technology (KIIT) has announced the KIITEE 2025 result for Phase 1. Candidates who appeared for the exam can now check their results online at the official ...

If the Phase 1 trial is successful, and assuming a partnership or other funding, Vaxart expects to conduct a Phase 2 safety and immunogenicity study that could potentially begin as early as the ...

Attorney General Pam Bondi “scrambled” to find Epstein material to appease the far right over the failed Phase 1 release of the files ... “Phase 2, when (or if) it happens, is likely ...

Phase 4 saw TV shows folded into the MCU's interconnected storylines more than ever before and this has continued throughout Phase 5 and the already-confirmed Phase 6, which will wrap up with an ...

For the next two weeks, the Cardinals will be in Phase 1. What is allowed in Phase 1 ... Players choose the other 2 hours for weights, etc. Things will ramp up into Phase 2 the week of May ...

The Mumbai Metropolitan Region Development Authority (MMRDA) plans to conduct trial runs on Phase 1 of Mumbai Metro’s Line 9 this week after a 4.9-km completed stretch between Dahisar (East) and ...

The first patient has been dosed in a Phase 1 clinical study testing AMX0114, an experimental therapy being developed by Almylyx Pharmaceuticals for amyotrophic lateral sclerosis (ALS). The treatment ...

Base remains one of the top L2 chains in terms of liquidity and DEX trades. Coinbase’s layer-2 network Base received Phase 1 decentralized status, announced Hsiao-Wei Wang, co-director of the Ethereum ...

Vertex Pharmaceuticals is conducting the pivotal phase 3 portion of a phase 1/2/3 study of zimislecel (formerly VX-880) in those with type 1 diabetes who have had severe hypoglycemic events.